Skip to main content
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · IEX Real-Time Price · USD
0.265
+0.009 (3.51%)
May 2, 2024, 1:09 PM EDT - Market open

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals had revenue of $5.49M in the twelve months ending December 31, 2023, with 239.77% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $1.24M with 163.99% year-over-year growth. In the fiscal year ending June 30, 2023, InMed Pharmaceuticals had annual revenue of $4.14M with 279.61% growth.

Revenue (ttm)
$5.49M
Revenue Growth
+239.77%
P/S Ratio
0.28
Revenue / Employee
$422,081
Employees
13
Market Cap
1.61M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20234.14M3.05M279.61%
Jun 30, 20221.09M--
Jun 30, 20210--
Jun 30, 20200--
Jun 30, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

INM News

More News